(Corvallis – Ore. ) The Oregon State University scientist who led the discovery that a pair of hemp compounds can block the coronavirus from entering human cells, thinks preclinical trials will happen within a few months.
Preclinical research involves using cell cultures and/or animal models to test the safety and efficacy of a new drug candidate, Richard van Breemen explains.
The U.S. Food and Drug Administration requires those types of studies, before any clinical testing in humans can begin, he said. The researcher with OSU’s Global Hemp Innovation Center, Linus Pauling Institute and College of Pharmacy, says, “We need preclinical trials to prove the efficacy of what we discovered, and I think that will happen very soon, in the next few months.”
Three weeks ago van Breemen, O.S.U. colleague Ruth Muchiri and five collaborators from Oregon Health and Science University published a study in the Journal of Natural Products. It showed hemp compounds identified via a chemical screening technique invented at O.S.U. display the ability to prevent infection from the virus that causes COVID-19.
They found that a pair of cannabinoid acids bind to the SARS-CoV-2 spike protein, blocking a step in the process the virus uses to infect people. The study continues to generate significant attention from around the world, including from several companies interested in collaborating with Oregon State for further work on the hemp compounds, van Breemen said.
“I’m…
Original Author Link click here to read complete story..
(Corvallis – Ore. ) The Oregon State University scientist who led the discovery that a pair of hemp compounds can block the coronavirus from entering human cells, thinks preclinical trials will happen within a few months.
Preclinical research involves using cell cultures and/or animal models to test the safety and efficacy of a new drug candidate, Richard van Breemen explains.
The U.S. Food and Drug Administration requires those types of studies, before any clinical testing in humans can begin, he said. The researcher with OSU’s Global Hemp Innovation Center, Linus Pauling Institute and College of Pharmacy, says, “We need preclinical trials to prove the efficacy of what we discovered, and I think that will happen very soon, in the next few months.”
Three weeks ago van Breemen, O.S.U. colleague Ruth Muchiri and five collaborators from Oregon Health and Science University published a study in the Journal of Natural Products. It showed hemp compounds identified via a chemical screening technique invented at O.S.U. display the ability to prevent infection from the virus that causes COVID-19.
They found that a pair of cannabinoid acids bind to the SARS-CoV-2 spike protein, blocking a step in the process the virus uses to infect people. The study continues to generate significant attention from around the world, including from several companies interested in collaborating with Oregon State for further work on the hemp compounds, van Breemen said.
“I’m…
